ClinicalTrials.gov
ClinicalTrials.gov Menu

Autoantibody Reduction Therapy in Patients With Idiopathic Pulmonary Fibrosis (ART-IPF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01969409
Recruitment Status : Completed
First Posted : October 25, 2013
Last Update Posted : October 20, 2017
Sponsor:
Collaborator:
National Institutes of Health (NIH)
Information provided by (Responsible Party):
Steven R. Duncan, MD, University of Alabama at Birmingham

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 18, 2017
  Actual Study Completion Date : October 18, 2017